Daniel Lindqvist1, Owen M Wolkowitz2, Synthia Mellon3, Rachel Yehuda4, Janine D Flory4, Clare Henn-Haase5, Linda M Bierer4, Duna Abu-Amara5, Michelle Coy6, Thomas C Neylan6, Iouri Makotkine4, Victor I Reus6, Xiaodan Yan5, Nicole M Taylor7, Charles R Marmar8, Firdaus S Dhabhar7. 1. Department of Psychiatry, University of California, San Francisco (UCSF), School of Medicine, San Francisco, CA, United States; Department of Clinical Sciences, Section for Psychiatry, Lund University, Lund, Sweden. 2. Department of Psychiatry, University of California, San Francisco (UCSF), School of Medicine, San Francisco, CA, United States. Electronic address: Owen.Wolkowitz@ucsf.edu. 3. Department of OB/GYN and Reproductive Sciences, University of California, San Francisco (UCSF), School of Medicine, San Francisco, CA, United States. 4. Department of Psychiatry, MSSM/James J. Peters Veterans Administration Medical Center, NY, United States. 5. Steven and Alexandra Cohen Veterans Center for Posttraumatic Stress and Traumatic Brain Injury, Department of Psychiatry, NYU, NY, United States. 6. Department of Psychiatry, University of California, San Francisco (UCSF), School of Medicine, San Francisco, CA, United States. 7. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States. 8. Steven and Alexandra Cohen Veterans Center for Posttraumatic Stress and Traumatic Brain Injury, Department of Psychiatry, NYU, NY, United States. Electronic address: Charles.Marmar@nyumc.org.
Abstract
BACKGROUND: Chronic inflammation may be involved in combat-related post-traumatic stress disorder (PTSD) and may help explain comorbid physical diseases. However, the extent to which combat exposure per se, depression, or early life trauma, all of which are associated with combat PTSD, may confound the relationship between PTSD and inflammation is unclear. METHODS: We quantified interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and C-reactive protein (CRP) in 51 combat-exposed males with PTSD and 51 combat-exposed males without PTSD, and assessed PTSD and depression severity as well as history of early life trauma. To decrease the possibility of Type I errors, we summed standardized scores of IL-1β, IL-6, TNFα, IFNγ and CRP into a total "pro-inflammatory score". PTSD symptom severity was assessed with the Clinician Administered PTSD Scale (CAPS) rating scale. RESULTS: Subjects with PTSD had significantly higher pro-inflammatory scores compared to combat-exposed subjects without PTSD (p=0.006), and even after controlling for early life trauma, depression diagnosis and severity, body mass index, ethnicity, education, asthma/allergies, time since combat and the use of possibly confounding medications (p=0.002). Within the PTSD group, the pro-inflammatory score was not significantly correlated with depressive symptom severity, CAPS total score, or with the number of early life traumas. CONCLUSIONS: Combat-related PTSD in males is associated with higher levels of pro-inflammatory cytokines, even after accounting for depression and early life trauma. These results, from one of the largest studies of inflammatory cytokines in PTSD to date, suggest that immune activation may be a core element of PTSD pathophysiology more so than a signature of combat exposure alone.
BACKGROUND:Chronic inflammation may be involved in combat-related post-traumatic stress disorder (PTSD) and may help explain comorbid physical diseases. However, the extent to which combat exposure per se, depression, or early life trauma, all of which are associated with combat PTSD, may confound the relationship between PTSD and inflammation is unclear. METHODS: We quantified interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and C-reactive protein (CRP) in 51 combat-exposed males with PTSD and 51 combat-exposed males without PTSD, and assessed PTSD and depression severity as well as history of early life trauma. To decrease the possibility of Type I errors, we summed standardized scores of IL-1β, IL-6, TNFα, IFNγ and CRP into a total "pro-inflammatory score". PTSD symptom severity was assessed with the Clinician Administered PTSD Scale (CAPS) rating scale. RESULTS: Subjects with PTSD had significantly higher pro-inflammatory scores compared to combat-exposed subjects without PTSD (p=0.006), and even after controlling for early life trauma, depression diagnosis and severity, body mass index, ethnicity, education, asthma/allergies, time since combat and the use of possibly confounding medications (p=0.002). Within the PTSD group, the pro-inflammatory score was not significantly correlated with depressive symptom severity, CAPS total score, or with the number of early life traumas. CONCLUSIONS: Combat-related PTSD in males is associated with higher levels of pro-inflammatory cytokines, even after accounting for depression and early life trauma. These results, from one of the largest studies of inflammatory cytokines in PTSD to date, suggest that immune activation may be a core element of PTSD pathophysiology more so than a signature of combat exposure alone.
Authors: Sian M J Hemmings; Stefanie Malan-Müller; Leigh L van den Heuvel; Brittany A Demmitt; Maggie A Stanislawski; David G Smith; Adam D Bohr; Christopher E Stamper; Embriette R Hyde; James T Morton; Clarisse A Marotz; Philip H Siebler; Maarten Braspenning; Wim Van Criekinge; Andrew J Hoisington; Lisa A Brenner; Teodor T Postolache; Matthew B McQueen; Kenneth S Krauter; Rob Knight; Soraya Seedat; Christopher A Lowry Journal: Psychosom Med Date: 2017-10 Impact factor: 4.312
Authors: Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak Journal: Psychoneuroendocrinology Date: 2014-10-22 Impact factor: 4.905
Authors: Murray B Stein; Chia-Yen Chen; Robert J Ursano; Tianxi Cai; Joel Gelernter; Steven G Heeringa; Sonia Jain; Kevin P Jensen; Adam X Maihofer; Colter Mitchell; Caroline M Nievergelt; Matthew K Nock; Benjamin M Neale; Renato Polimanti; Stephan Ripke; Xiaoying Sun; Michael L Thomas; Qian Wang; Erin B Ware; Susan Borja; Ronald C Kessler; Jordan W Smoller Journal: JAMA Psychiatry Date: 2016-07-01 Impact factor: 21.596
Authors: Stefan O Reber; Philip H Siebler; Nina C Donner; James T Morton; David G Smith; Jared M Kopelman; Kenneth R Lowe; Kristen J Wheeler; James H Fox; James E Hassell; Benjamin N Greenwood; Charline Jansch; Anja Lechner; Dominic Schmidt; Nicole Uschold-Schmidt; Andrea M Füchsl; Dominik Langgartner; Frederick R Walker; Matthew W Hale; Gerardo Lopez Perez; Will Van Treuren; Antonio González; Andrea L Halweg-Edwards; Monika Fleshner; Charles L Raison; Graham A Rook; Shyamal D Peddada; Rob Knight; Christopher A Lowry Journal: Proc Natl Acad Sci U S A Date: 2016-05-16 Impact factor: 11.205